ALGIPHARMA AS
Signals
- Driftsunderskudd 2025 Siste driftsresultat er negativt (−6,7 mill kr).
ALGIPHARMA AS is registered as a limited company in Bærum, Akershus with organisation number 964911444. The business is classified under research and experimental development on natural sciences and engineering (NACE 72.100). The company was incorporated in 1992 and has 6 registered employees. Registered share capital is NOK 2.8m, divided into 11278404 shares. The company's stated purpose is: “Forskning og kommersialisering av forskningsprosjekter og forskningsresultater knyttet til alginater og annen bioteknologi og virksomhet i tilknytning til detter, herunder deltakelse i andre virksomheter gjennom aksjeeie eller på annen måte.”. The most recent filed accounts, for the 2025 financial year, show NOK 29,000 in revenue and NOK −6.7m in operating profit.
Former names: KULA AS, ALGIPHARMA HOLDING AS
Key figures · 2025
Financial health · 2025
Who owns ALGIPHARMA AS?
ALGIPHARMA AS has 1 registered shareholder:
- ALGIPHARMA HOLDING AS 100.0%
Frequently asked questions about ALGIPHARMA AS
Who owns ALGIPHARMA AS?
ALGIPHARMA HOLDING AS is the largest registered owner, with 100.0%.
What is the revenue of ALGIPHARMA AS?
ALGIPHARMA AS had revenue of NOK 29,000 in 2025.
Who is the general manager of ALGIPHARMA AS?
Yngvar Peter Berg is registered as general manager of ALGIPHARMA AS.
Where is ALGIPHARMA AS based?
ALGIPHARMA AS has its business address in Sandvika.
Property
19 companies are registered at this address.
The address this company is registered at, from the company register and matched against the cadastre. It does not say who owns the property — a company may be a tenant, and the address is often its accountant's. Source: Brønnøysundregistrene and © Kartverket.
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 02.09.2026.